Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 48
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Cariou, Alain Deye, Nicolas Vivien, Benoît Richard, Olivier Pichon, Nicolas Bourg, Angèle Huet, Loïc Buleon, Clément Frey, Jérôme Asfar, Pierre Legriel, Stéphane Narcisse, Sophie Mathonnet, Armelle Cravoisy, Aurélie Dequin, Pierre-François Wiel, Eric Razazi, Keyvan Daubin, Cédric Kimmoun, Antoine Lamhaut, Lionel Marx, Jean-Sébastien de la Garanderie, Didier Payen Ecollan, Patrick Combes, Alain Spaulding, Christian Barat, Florence Ben Boutieb, Myriam Coste, Joël Chiche, Jean-Daniel Pène, Frédéric Mira, Jean-Paul Treluyer, Jean-Marc Hermine, Olivier and Carli, Pierre 2016. Early High-Dose Erythropoietin Therapy After Out-of-Hospital Cardiac Arrest. Journal of the American College of Cardiology, Vol. 68, Issue. 1, p. 40.


    Dey, Soumyadeep Li, Xiaoxia Teng, Ruifeng Alnaeeli, Mawadda Chen, ZhiYong Rogers, Heather and Noguchi, Constance Tom 2016. Erythropoietin regulates POMC expression via STAT3 and potentiates leptin response. Journal of Molecular Endocrinology, Vol. 56, Issue. 2, p. 55.


    Lamon, Séverine Zacharewicz, Evelyn Arentson-Lantz, Emily Gatta, Paul A. Della Ghobrial, Lobna Gerlinger-Romero, Frederico Garnham, Andrew Paddon-Jones, Douglas and Russell, Aaron P. 2016. Erythropoietin Does Not Enhance Skeletal Muscle Protein Synthesis Following Exercise in Young and Older Adults. Frontiers in Physiology, Vol. 7,


    Tunc Ata, Melek Turgut, Günfer Akbulut, Metin Kocyigit, Ali Karabulut, Aysun Senol, Hande and Turgut, Sebahat 2016. Effect of Erythropoietin and Stem Cells on Traumatic Brain Injury. World Neurosurgery, Vol. 89, p. 355.


    Xu, Qianghua Zhang, Chi Zhang, Dongsheng Jiang, Huapeng Peng, Sihua Liu, Yang Zhao, Kai Wang, Congcong and Chen, Liangbiao 2016. Analysis of the erythropoietin of a Tibetan Plateau schizothoracine fish (Gymnocypris dobula) reveals enhanced cytoprotection function in hypoxic environments. BMC Evolutionary Biology, Vol. 16, Issue. 1,


    Alnaeeli, Mawadda and Noguchi, Constance Tom 2015. Erythropoietin and obesity-induced white adipose tissue inflammation: redefining the boundaries of the immunometabolism territory. Adipocyte, Vol. 4, Issue. 2, p. 153.


    Li, Jun Guo, Weichun Xiong, Min Han, Heng Chen, Jie Mao, Dan Tang, Bing Yu, Hualong and Zeng, Yun 2015. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury. International Journal of Molecular Medicine,


    Meyer, F.R.L. Steinborn, R. Grausgruber, H. Wolfesberger, B. and Walter, I. 2015. Expression of platelet-derived growth factor BB, erythropoietin and erythropoietin receptor in canine and feline osteosarcoma. The Veterinary Journal, Vol. 206, Issue. 1, p. 67.


    Prakash, Jai 2015. Updates in the management of diabetic nephropathy. Clinical Queries: Nephrology, Vol. 4, Issue. 1-2, p. 9.


    Satoh, Kimio 2015. Cyclophilin A in Cardiovascular Homeostasis and Diseases. The Tohoku Journal of Experimental Medicine, Vol. 235, Issue. 1, p. 1.


    Souma, Tomokazu Suzuki, Norio and Yamamoto, Masayuki 2015. Renal erythropoietin-producing cells in health and disease. Frontiers in Physiology, Vol. 6,


    Alnaeeli, M. Raaka, B. M. Gavrilova, O. Teng, R. Chanturiya, T. and Noguchi, C. T. 2014. Erythropoietin Signaling: A Novel Regulator of White Adipose Tissue Inflammation During Diet-Induced Obesity. Diabetes, Vol. 63, Issue. 7, p. 2415.


    Cokic, Bojana B. Beleslin Cokic, Vladan P. Suresh, Sukanya Wirt, Stacey and Noguchi, Constance Tom 2014. Nitric oxide and hypoxia stimulate erythropoietin receptor via MAPK kinase in endothelial cells. Microvascular Research, Vol. 92, p. 34.


    Corwin, Howard L. and Napolitano, Lena M. 2014. Erythropoietin for critically ill trauma patients. Journal of Trauma and Acute Care Surgery, Vol. 77, Issue. 5, p. 774.


    Kai, Shinichi Tanaka, Tomoharu Matsuyama, Tomonori Suzuki, Kengo and Hirota, Kiichi 2014. The volatile anesthetic isoflurane differentially suppresses the induction of erythropoietin synthesis elicited by acute anemia and systemic hypoxemia in mice in an hypoxia-inducible factor-2-dependent manner. European Journal of Pharmacology, Vol. 732, p. 43.


    Lamon, Séverine Zacharewicz, Evelyn Stephens, Andrew N. and Russell, Aaron P. 2014. EPO-receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis. Physiological Reports, Vol. 2, Issue. 3, p. n/a.


    Liang, Ke Qiu, Songbo Lu, Yang and Fan, Zhen 2014. Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells. Cancer Biology & Therapy, Vol. 15, Issue. 1, p. 89.


    Miljus, N. Heibeck, S. Jarrar, M. Micke, M. Ostrowski, D. Ehrenreich, H. and Heinrich, R. 2014. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways. Neuroscience, Vol. 258, p. 218.


    Wang, Li Di, Lijun and Noguchi, Constance Tom 2014. AMPK is involved in mediation of erythropoietin influence on metabolic activity and reactive oxygen species production in white adipocytes. The International Journal of Biochemistry & Cell Biology, Vol. 54, p. 1.


    Kurtz, Armin Wenger, Roland H. and Eckardt, Kai-Uwe 2013. Seldin and Giebisch's The Kidney.


    ×
  • Expert Reviews in Molecular Medicine, Volume 10
  • 2008, e36

Survival and proliferative roles of erythropoietin beyond the erythroid lineage

  • Constance Tom Noguchi (a1), Li Wang (a1), Heather M. Rogers (a1), Ruifeng Teng (a1) and Yi Jia (a1)
  • DOI: http://dx.doi.org/10.1017/S1462399408000860
  • Published online: 01 December 2008
Abstract

Since the isolation and purification of erythropoietin (EPO) in 1977, the essential role of EPO for mature red blood cell production has been well established. The cloning of the EPO gene and production of recombinant human EPO led to the widespread use of EPO in treating patients with anaemia. However, the biological activity of EPO is not restricted to regulation of erythropoiesis. EPO receptor (EPOR) expression is also found in endothelial, brain, cardiovascular and other tissues, although at levels considerably lower than that of erythroid progenitor cells. This review discusses the survival and proliferative activity of EPO that extends beyond erythroid progenitor cells. Loss of EpoR expression in mouse models provides evidence for the role of endogenous EPO signalling in nonhaematopoietic tissue during development or for tissue maintenance and/or repair. Determining the extent and distribution of receptor expression provides insights into the potential protective activity of EPO in brain, heart and other nonhaematopoietic tissues.

Copyright
Corresponding author
*Corresponding author: Constance Tom Noguchi, Molecular Medicine Branch, NIDDK, National Institutes of Health, Building 10, Room 9N319, 10 CENTER DR MSC-1822, Bethesda, MD 20892-1822, USA. Tel: +1 301 496 1163; Fax: +1 301 402 0101; E-mail: cnoguchi@helix.nih.gov
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2F.K. Lin (1985) Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A 82, 7580-7584

3K. Jacobs (1985) Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313, 806-810

10E. Tsuda (1990) The role of carbohydrate in recombinant human erythropoietin. Eur J Biochem 188, 405-411

11E.D. Zanjani (1981) Studies on the liver to kidney switch of erythropoietin production. J Clin Invest 67, 1183-1188

13N. Obara (2008) Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood 111, 5223-5232

14S.E. Juul , A.T. Yachnis and R.D. Christensen (1998) Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 52, 235-249

16J. Kochling , P.T. Curtin and A. Madan (1998) Regulation of human erythropoietin gene induction by upstream flanking sequences in transgenic mice. Br J Haematol 103, 960-968

17M.C. Bondurant and M.J. Koury (1986) Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol Cell Biol 6, 2731-2733

18C.C. Tan , K.U. Eckardt and P.J. Ratcliffe (1991) Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int 40, 69-76

20P.H. Maxwell (1993) Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44, 1149-1162

22K.U. Eckardt (1993) Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int 43, 815-823

23G.L. Semenza (1991) Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A 88, 8725-8729

24G.L. Semenza and G.L. Wang (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12, 5447-5454

25D.L. Galson (1995) The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1. Mol Cell Biol 15, 2135-2144

27E. Metzen and P.J. Ratcliffe (2004) HIF hydroxylation and cellular oxygen sensing. Biol Chem 385, 223-230

28T.G. Smith , P.A. Robbins and P.J. Ratcliffe (2008) The human side of hypoxia-inducible factor. Br J Haematol 141, 325-334

29C.J. Hu (2007) The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 18, 4528-4542

30M.J. Percy (2006) A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A 103, 654-659

31S.O. Ang (2002) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32, 614-621

33E.B. Rankin (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117, 1068-1077

34J.C. Chavez (2006) The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26, 9471-9481

35M. Gruber (2007) Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 104, 2301-2306

36E. Zelzer (1998) Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 17, 5085-5094

37M.J. Percy (2008) A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med 358, 162-168

38K.L. Blanchard (1992) Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol 12, 5373-5385

40T. Makita , S.A. Duncan and H.M. Sucov (2005) Retinoic acid, hypoxia, and GATA factors cooperatively control the onset of fetal liver erythropoietin expression and erythropoietic differentiation. Dev Biol 280, 59-72

41T. Makita (2001) A developmental transition in definitive erythropoiesis: erythropoietin expression is sequentially regulated by retinoic acid receptors and HNF4. Genes Dev 15, 889-901

42J.A. Alberta (2003) Role of the WT1 tumor suppressor in murine hematopoiesis. Blood 101, 2570-2574

43C. Dame (2006) Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene. Blood 107, 4282-4290

44T. Sanchez-Elsner (2004) A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads. J Mol Biol 336, 9-24

47P.P. Pandolfi (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 11, 40-44

48T. Hoshino (2008) Reduced BMP4 abundance in Gata2 hypomorphic mutant mice result in uropathies resembling human CAKUT. Genes Cells 13, 159-170

49X. Gao (1998) Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol Cell Biol 18, 2901-2911

50T. Peterkin , A. Gibson and R. Patient (2007) Redundancy and evolution of GATA factor requirements in development of the myocardium. Dev Biol 311, 623-635

51C.D. Capo-Chichi (2005) Perception of differentiation cues by GATA factors in primitive endoderm lineage determination of mouse embryonic stem cells. Dev Biol 286, 574-586

52C. Dame (2004) Hepatic erythropoietin gene regulation by GATA-4. J Biol Chem 279, 2955-2961

55H.M. Rogers (2008) Hypoxia alters progression of the erythroid program. Exp Hematol 36, 17-27

57M. Ogilvie (2000) Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 275, 39754-39761

58H. Wu (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83, 59-67

59C.S. Lin (1996) Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 10, 154-164

61T. Chiba , Y. Ikawa and K. Todokoro (1991) GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. Nucleic Acids Res 19, 3843-3848

62A. Anagnostou (1994) Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci U S A 91, 3974-3978

63E. Morishita (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76, 105-116

65S.E. Juul (1998) Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43, 40-49

66M.O. Arcasoy (2008) The non-haematopoietic biological effects of erythropoietin. Br J Haematol 141, 14-31

69R.S. Syed (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511-516

70A.D. D'Andrea and Y. Zhu (1996) Cloning and functional analysis of erythropoietin-, interleukin-3- and thrombopoietin-inducible genes. Stem Cells 14 Suppl 1, 82-87

71D.J. Hilton (1995) Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proc Natl Acad Sci U S A 92, 190-194

73E. Parganas (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, 385-395

74M. Funakoshi-Tago (2008) Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity. Mol Cell Biol 28, 1792-1801

75O. Livnah (1999) Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987-990

76H. Neubauer (1998) Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93, 397-409

77E.J. Baxter (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365, 1054-1061

78R.L. Levine (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7, 387-397

79T. Horn (2006) Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases. J Mol Diagn 8, 299-304

80L.M. Scott (2007) JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 356, 459-468

81M.A. Kerenyi (2008) Stat 5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. Blood 112, 3878-3888

82F. Grebien (2008) Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. Blood 111, 4511-4522

84A.D. D'Andrea (1991) The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol 11, 1980-1987

85L. Supino-Rosin (1999) A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation. Eur J Biochem 263, 410-419

86T. Nahari (2008) A transplanted NPVY sequence in the cytosolic domain of the erythropoietin receptor enhances maturation. Biochem J 410, 409-416

87A.W. Gross and H.F. Lodish (2006) Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). J Biol Chem 281, 2024-2032

89L. Meyer (2007) beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood 109, 5215-5222

90M.O. Arcasoy , K.W. Harris and B.G. Forget (1999) A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation. Exp Hematol 27, 63-74

91R. Kralovics and J.T. Prchal (2001) Genetic heterogeneity of primary familial and congenital polycythemia. Am J Hematol 68, 115-121

93K. Chin (1995) Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs. Nucleic Acids Res 23, 3041-3049

94T. Sato (1998) Induction of the erythropoietin receptor gene and acquisition of responsiveness to erythropoietin by stem cell factor in HML/SE, a human leukemic cell line. J Biol Chem 273, 16921-16926

95L.I. Zon (1991) Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci U S A 88, 10638-10641

96M.J. Weiss , G. Keller and S.H. Orkin (1994) Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev 8, 1184-1197

97Q. Zhang (2008) Synergistic upregulation of erythropoietin receptor (EPO-R) expression by sense and antisense EPO-R transcripts in the canine lung. Proc Natl Acad Sci U S A 105, 7612-7617

98L. Maouche (1995) A CCACC motif mediates negative transcriptional regulation of the human erythropoietin receptor. Eur J Biochem 233, 793-799

99Z.Y. Liu , K. Chin and C.T. Noguchi (1994) Tissue specific expression of human erythropoietin receptor in transgenic mice. Dev Biol 166, 159-169

100R. Lee (2001) Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis. Blood 98, 1408-1415

101X. Yu (2001) The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor null mouse. Blood 98, 475-477

102Z.Y. Chen , R. Warin and C.T. Noguchi (2006) Erythropoietin and normal brain development: receptor expression determines multi-tissue response. Neurodegener Dis 3, 68-75

103C.T. Noguchi (2007) Role of erythropoietin in the brain. Crit Rev Oncol Hematol 64, 159-171

104A. Anagnostou (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 87, 5978-5982

106Z.Z. Chong , J.Q. Kang and K. Maiese (2002) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106, 2973-2979

107B.B. Beleslin-Cokic (2004) Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104, 2073-2080

108N.L. Kanagy (2003) Erythropoietin administration in vivo increases vascular nitric oxide synthase expression. J Cardiovasc Pharmacol 42, 527-533

110C. Defouilloy (1998) Polycythemia impairs vasodilator response to acetylcholine in patients with chronic hypoxemic lung disease. Am J Respir Crit Care Med 157, 1452-1460

112Y. Yasuda (1998) Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 273, 25381-25387

113N. Kertesz (2004) The role of erythropoietin in regulating angiogenesis. Dev Biol 276, 101-110

114C. Heeschen (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346

115F.H. Bahlmann (2004) Erythropoietin regulates endothelial progenitor cells. Blood 103, 921-926

116N. Urao (2006) Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98, 1405-1413

117K. Satoh (2006) Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation 113, 1442-1450

118M. Nakano (2007) Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res 100, 662-669

119T. Saito (1983) Serum erythropoietin titres in the anaemia of premature infants. Br J Haematol 54, 53-58

120J.A. Stockman , 3rd (1984) Anemia of prematurity: determinants of the erythropoietin response. J Pediatr 105, 786-792

121R.K. Ohls (1997) The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr 131, 661-665

122G. Turker (2005) The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants. Am J Perinatol 22, 449-455

124L.P. Aiello (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 92, 10457-10461

125M. Morita (2003) HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 22, 1134-1146

127E.A. Friedman , C.D. Brown and D.H. Berman (1995) Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 26, 202-208

128Z. Tong (2008) Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A 105, 6998-7003

129D. Watanabe (2005) Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353, 782-792

130I.G. Lee , S.L. Chae and J.C. Kim (2006) Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye 20, 546-552

131C. Liu (1997) Regulated human erythropoietin receptor expression in mouse brain. J Biol Chem 272, 32395-32400

133L. Calvillo (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 100, 4802-4806

135N. Suzuki (2002) Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood 100, 2279-2288

136H. Tada (2006) Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovasc Res 71, 466-477

137C.J. Parsa (2003) A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112, 999-1007

138C. Moon (2003) Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci U S A 100, 11612-11617

139T. Rui (2005) Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc Res 65, 719-727

140D. Burger (2006) Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72, 51-59

141D.A. Narmoneva (2004) Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 110, 962-968

142B.D. Westenbrink (2007) Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 28, 2018-2027

143P. van der Meer (2005) Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 46, 125-133

145H.H. Marti (1997) Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int 51, 416-418

146H.H. Marti (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8, 666-676

147P.T. Tsai (2006) A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 26, 1269-1274

148Z.Y. Chen (2007) Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem 282, 25875-25883

149K. Chin (2000) Production and processing of erythropoietin receptor transcripts in brain. Brain Res Mol Brain Res 81, 29-42

152M. Sakanaka (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95, 4635-4640

153Y. Sadamoto (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253, 26-32

156K. Prass (2003) Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34, 1981-1986

157S. Malhotra (2006) Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 83, 19-27

159C. Grimm (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8, 718-724

160C. Grimm (2004) Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24, 5651-5658

161A. Xenocostas (2005) The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol 61, 189-195

162W.A. Banks (2004) Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur J Pharmacol 505, 93-101

163M.L. Brines (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97, 10526-10531

167Z.Z. Chong , J.Q. Kang and K. Maiese (2003) Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol 138, 1107-1118

168N. Byts (2008) Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death Differ 15, 783-792

169F. Zhang (2006) Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J Neurosci Res 83, 1241-1251

170M. Digicaylioglu and S.A. Lipton (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412, 641-647

171J. Liu (2005) Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36, 1264-1269

172L. Wang (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35, 1732-1737

173L. Wang (2006) Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 26, 5996-6003

174L. Wang (2008) Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab 28, 1361-1368

175F.F. Gonzalez (2007) Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 29, 321-330

176A.L. Siren (2006) Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain 129, 480-489

178H. Ehrenreich (2007) Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130, 2577-2588

179H. Ehrenreich (2007) Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 12, 206-220

180V. Skibeli , G. Nissen-Lie and P. Torjesen (2001) Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 98, 3626-3634

181S. Elliott (2003) Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 21, 414-421

182B. Ling (2005) Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease. Clin Nephrol 63, 327-334

183T.L. Warwood (2005) Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol 25, 725-730

184A.J. Sytkowski (1999) An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties. J Biol Chem 274, 24773-24778

185A.J. Sytkowski (1998) Human erythropoietin dimers with markedly enhanced in vivo activity. Proc Natl Acad Sci U S A 95, 1184-1188

186G.G. Kochendoerfer (2003) Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein. Science 299, 884-887

187J.M. Topf (2008) CERA: third-generation erythropoiesis-stimulating agent. Expert Opin Pharmacother 9, 839-849

189N.C. Wrighton (1996) Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273, 458-464

190Z. Liu (2007) A potent erythropoietin-mimicking human antibody interacts through a novel binding site. Blood 110, 2408-2413

191W.M. Bernhardt (2006) Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 17, 1970-1978

192M.M. Hsieh (2007) HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood 110, 2140-2147

193K. Heinicke (2006) Excessive erythrocytosis in adult mice overexpressing erythropoietin leads to hepatic, renal, neuronal, and muscular degeneration. Am J Physiol Regul Integr Comp Physiol 291, R947-956

194S. Erbayraktar (2003) Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A 100, 6741-6746

195F. Fiordaliso (2005) A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci U S A 102, 2046-2051

196M. Leist (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305, 239-242

197L. Wang (2007) The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells. J Biol Chem 282, 32462-32470

198M. Brines (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A 101, 14907-14912

199M. Um , A.W. Gross and H.F. Lodish (2007) A “classical” homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal 19, 634-645

200J. Nadam (2007) Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol Dis 25, 412-426

201T.B. Drueke (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355, 2071-2084

202A.K. Singh (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355, 2085-2098

203W. Jelkmann (2008) The erythropoietin receptor in normal and cancer tissues. Crit Rev Oncol Hematol 67, 39-61

205C.M. Glaser (2001) Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50, 705-715

206B. Leyland-Jones (2003) Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 4, 459-460

207M. Henke (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362, 1255-1260

208C.L. Bennett (2008) Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299, 914-924

209J.D. Rizzo (2008) Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 26, 132-149

V.M. Hodges (2007) Pathophysiology of anemia and erythorcytosis. Crit Rev Oncol Hematol 64, 139-158

R. Sasaki (2003) Pleiotropic functions of erythropoietin. Intern Med 42, 142-149

A.J. Sytkowski (2004) Erythropoietin: Blood, Brain and Beyond, Wiley-VCH, Weinheim, Germany

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×